文献速递肾癌与肾肿瘤

肥胖与微创肾切除术后30天结局的关系

Obesity and 30-Day Outcomes Following Minimally Invasive Nephrectomy.
PubMed 文献 · Urology · 2018-08-16

基于NSQIP数据库2012至2016年21,334例接受微创部分或根治性肾切除术的成人患者,按WHO肥胖分级分析。多变量模型同时纳入肥胖分级与合并症评分后,合并症而非肥胖与术后总体并发症风险增加相关;肥胖独立关联手术时间延长和出院至继续照护机构,但不关联30天再入院。

要点

  • 肥胖本身不独立预测微创肾切除术后30天总体并发症或再入院风险。
  • 合并症是术后总体并发症风险增加的主要相关因素。
  • 肥胖独立关联手术时间延长和出院至继续照护机构。

核心结论

  • BMI不独立预测微创部分或根治性肾切除术后30天内总体并发症或再入院的 likelihood,不应视为手术主要障碍。

研究设计与样本

  • 回顾性队列研究,使用美国国家手术质量改进项目数据库,纳入2012至2016年接受微创部分肾切除术(MIPN)或微创根治性肾切除术(MIRN)的成人患者共21,334例(MIPN=10,444,MIRN=10,890)。
  • 按WHO肥胖分类分层:非肥胖(BMI 18.5-29.9 kg/m2)、I级肥胖(BMI 30-34.9 kg/m2)、II级肥胖(BMI 35-39.9 kg/m2)、III级肥胖(BMI≥40 kg/m2)。
  • 采用多变量logistic回归,交替纳入肥胖分级、合并症评分及两者,评估与术后结局的关联。

主要发现

  • 仅纳入肥胖分级或合并症评分时,两者均与30天总体并发症风险增加相关。
  • 同时纳入肥胖分级与合并症评分后,合并症而非肥胖与术后并发症风险增加相关。
  • 肥胖与计划外再入院无关联。
  • 在完整模型中,肥胖独立关联手术时间延长和出院至继续照护机构。

临床怎么用

  • 微创肾切除术前风险评估应综合考虑肥胖与合并症,而非仅因肥胖拒绝手术。
  • 对肥胖患者应关注手术时间延长和出院后继续照护的需求。

局限性

  • 原文摘要未报告具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between obesity and postoperative outcomes following minimally invasive partial nephrectomy (MIPN) and minimally invasive radical nephrectomy (MIRN). METHODS: Using the National Surgical Quality Improvement Project database, we identified adult patients who underwent either MIPN or MIRN from 2012 to 2016. Patients were stratified by body mass index (BMI) according the World Health Organization classification of obesity (nonobese [BMI 18.5-29.9 kg/m2], class I obesity [BMI 30-34.9 kg/m2], class II obesity [BMI 35-39.9 kg/m2], and class III obesity [BMI≥40 kg/m2]). Multivariable logistic regressions alternately including obesity class, comorbidity score, and both were used to evaluate the association among these variables with post-operative outcomes. RESULTS: A total of 21,334 patients (MIPN=10,444, MIRN=10,890) were included. When only obesity class or comorbidity score was included in our multivariable logistic regression model, both variables were associated with increased odds of overall 30-day complications. However, when both class or comorbidity were included in the model, comorbidity but not obesity was found to be associated with increased postoperative complications. Obesity was also not found to be associated with unplanned readmission. However, obesity was independently associated with prolonged operative time and discharge to continued care in the full model. CONCLUSION: This NSQIP study suggests that BMI does not independently predict the likelihood of overall complications or readmission within 30 days, and should not be considered a major barrier for MIPN or MIRN. Instead, obesity should be taken into consideration with other comorbidities when risk-stratifying patients prior to minimally invasive nephrectomy.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Sperling CD, Xia L, Berger IB, et al. Obesity and 30-Day Outcomes Following Minimally Invasive Nephrectomy. Urology. 2018. PMID: 30121194. doi:10.1016/j.urology.2018.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。